Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

1.19 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Operating Activities:
Net Income -177.119-101.944-87.758-58.574130.133-120.548-129.05-141.429-4.682-100.294-104.126-110.211-116.215-101.775-93.317-76.86-58.794-54.311-36.315-47.172-64.198-59.67-35.172-25.994-12.5
Depreciation & Amortization 0.5540.4270.2922.9343.6543.6833.3992.0560.7271.9282.8634.194.8875.3946.15910.0710.42211.20111.63512.87221.5320.57916.552.6212
Deferred Income Tax -5.09100.049-0.11-6.0140-12.6610.0163.55-0.0700116.9194.8172.577-26.524-20.365-6.9950000000
Stock Based Compensation 14.3411.5210.57713.27414.21811.6969.4727.4526.8437.0817.4216.4955.7075.4785.2746.57.9267.030000000
Change In Working Capital 2.6590.402-10.23131.079-58.287-44.774-59.257-43.547171.8912.2924.973-4.82110.2131.008-8.536-16.6-21.438-20.86448.112-7.94531.89410.1020.6321.0310.9
Accounts Receivables -0.982-0.0140.38153.227-50.608-1.0990.166-4.080.1240.4570.588-1.0280000000000000
Inventory -0.381000.3450.437-2.732-1.9486.227-5.789-0.1281.704-2.5050000000000000
Accounts Payables 6.4540.076-14.158-20.96920.097-18.857-7.17227.656.2031.2663.119-0.99510.365-5.238-2.794-2.2562.6191.6780000000
Other Working Capital -2.4320.343.546-1.524-28.213-22.086-50.303-73.344171.3530.697-0.438-0.293-0.1526.246-5.742-14.344-24.057-22.54248.112-7.94531.89410.1020.6321.0310.9
Other Non Cash Items 2.760.7440.054-131.57230.1031.3362.703-0.1766.44713.441-2.219.887-109.4492.71-1.1737.8147.9267.030.01-0.0113.0580.197020.8410
Operating Cash Flow -161.897-88.851-87.017-142.969113.807-148.607-185.394-175.628184.776-75.622-91.079-94.46-87.938-82.368-89.016-95.6-74.323-56.90923.442-42.256-7.716-28.792-17.99-1.501-9.6
Investing Activities:
Investments In Property Plant And Equipment -0.47-1.326-1.221-0.087-0.07-0.095-0.228-0.231-0.91-0.08-1.721-0.492-1.206-1.132-0.369-2.187-1.9-3.579-11.281-11.811-4.824-19.766-13.471-7.71-4.1
Acquisitions Net 49.47369.752-3.33111.013155.7850000.3350000-5.5610-20.0560000.0910.0480000
Purchases Of Investments -223.343-133.949-34.261-58.555-322.385-119.987-267.873-425.673-326.446-221.953-111.49-233.25-108.092-155.856-64.205-39.847-305.73-67.688-175.235-178.355-33.313-91.962-366.704-269.847-12.5
Sales Maturities Of Investments 173.8764.19737.592268166.6289.658318.623444.156210111.444212.625135.85176.62848.64176.344201.449119.67895.676170.404216.18265.437181.747387.345112.10821.8
Other Investing Activites -49.473-69.7523.331160.385-155.785169.67150.7518.4830.3352.170.130.0852.6250.0640.10720.0560.0010.0560.12314.372-27.476-22.794-0.75200
Investing Cash Flow -49.943-71.0782.11380.756-155.855169.57650.52218.252-117.021-108.41999.544-97.80769.955-113.84411.877159.415-187.95124.465-15.98940.479-0.12847.2256.418-165.4485.2
Financing Activities:
Debt Repayment 49.96148.868-11.7-216.58-1.285-2.004143.625-2.016-1.85982.425-1.574-1.443-3.589-38.48136.472-0.881-0.815-0.751-0.691-18.71304-3.909-1.5953.5
Common Stock Issued 138.82394.20537.08469.9700.7327.9873.6240.114202.271.08438.109160.781181.49655.4360.001213.09141.4510.5961.71250.3970.5740.718204.330
Common Stock Repurchased -0.824-0.864-2.675-1.026-0.941-0.972-1.679-0.621-0.357-0.887-0.873-0.285-0.108-0.149-0.0880000000000
Dividends Paid 0000000000000000000000000
Other Financing Activities 000000000.070-0.0260000042.7100-2.46600000
Financing Cash Flow 187.96142.20922.709-147.636-2.226-2.244149.9330.987-2.032283.808-1.38936.381157.084142.86691.82-0.88254.98640.7-0.095-19.46750.3974.574-3.191202.7353.4
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000000
Net Change In Cash -23.88-17.72-62.19890.151-44.27418.72515.061-156.38965.72399.7677.076-155.886139.101-53.34614.68162.935-7.2888.2567.358-21.24442.55323.007-14.76335.785-1
Cash At End Of Period 22.46546.34564.065126.26336.11280.38661.66146.6202.989137.26637.49930.423186.30947.208100.55485.87322.93830.22621.9714.61281.91539.36223.04837.8112